US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Canadian Phosphate Ltd (CP8N) 銘柄情報

Canadian Phosphate Ltd (CP8N)

0.00

0.00

( 0.00% )

更新日時： -

Canadian Phosphate Ltd (CP8N) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

-

( - )

買値

-

売値

-

出来高

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

-

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 231,553

発行済株式数

346,760,527

配当利回り

PER

-24.82

1 株当たり利益 (EPS)

-0.01

歳入

2.31M

純利益

-2.21M

Canadian Phosphate Limited supplies regenerative phosphate and organic fertilizers products in Australia and North America. The company holds interests in two rock phosphate mining projects, comprising the Wapiti project comprising an area of approximately 78 km²; and Fernie projects that covers an ... Canadian Phosphate Limited supplies regenerative phosphate and organic fertilizers products in Australia and North America. The company holds interests in two rock phosphate mining projects, comprising the Wapiti project comprising an area of approximately 78 km²; and Fernie projects that covers an area of approximately 108 km² in British Columbia, Canada. It also offers fused calcium magnesium silica phosphate products. The company was formerly known as Fertoz Limited and changed its name to Canadian Phosphate Limited in February 2025. Canadian Phosphate Limited was incorporated in 2010 and is based in Perth, Australia. 詳細を表示

セクター

-

業界

-

ウェブサイト

canadianphosphate.com

本社

Perth, Australia

設立

2026

Canadian Phosphate Ltd is listed in the sector of the オーストラリア証券取引所 with ticker CP8N. The last closing price for Canadian Phosphate was -. Over the last year, Canadian Phosphate shares have traded in a share price range of AUD 0.00 to AUD 0.00.

Canadian Phosphate currently has 346,760,527 shares in issue. Canadian Phosphate has a price to earnings ratio (PE ratio) of -24.82.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

CP8N - Frequently Asked Questions (FAQ)

What is the current Canadian Phosphate Ltd share price?

The current share price of Canadian Phosphate Ltd is AUD 0.00

How many Canadian Phosphate Ltd shares are in issue?

Canadian Phosphate Ltd has 346,760,527 shares in issue

What is the 1 year trading range for Canadian Phosphate Ltd share price?

Canadian Phosphate Ltd has traded in the range of AUD 0.00 to AUD 0.00 during the past year

What is the PE ratio of Canadian Phosphate Ltd?

The price to earnings ratio of Canadian Phosphate Ltd is -24.82

What is the cash to sales ratio of Canadian Phosphate Ltd?

The cash to sales ratio of Canadian Phosphate Ltd is 26.31

What is the registered address of Canadian Phosphate Ltd?

The registered address for Canadian Phosphate Ltd is 8 St Georges Terrace, Perth, Western Australia, 6000

What is the Canadian Phosphate Ltd website address?

The website address for Canadian Phosphate Ltd is canadianphosphate.com

Sleepy$$$

Sleepy$$$ 16分前

Outstanding Shares642,268,09705/29/2026Restricted625,012,64605/29/2026

Per otcmarkets.... float is tiny

Duke Knockem

Duke Knockem 19分前

I asked Belisarian holdings if they would take over Gs tickers, they didn't respond, but they 'liked' my post on Twitter. In 4 years it was only the second time they liked one of my post....🤷....to take with a grain of salt

nowwhat2

nowwhat2 23分前

STOP

https://www.youtube.com/watch?v=JNhayv6hBeo
https://investorshub.advfn.com/uimage/uploads/2026/6/12/netmygold_june_11_3m_daily_w_asian_guy.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/12/udfnigold_june_11_3y_w_asian_guy.jpg

https:/

nowwhat2

nowwhat2 24分前

STOP

https://www.youtube.com/watch?v=JNhayv6hBeo
https://investorshub.advfn.com/uimage/uploads/2026/6/12/netmygold_june_11_3m_daily_w_asian_guy.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/12/udfnigold_june_11_3y_w_asian_guy.jpg

https:/

axelvento

axelvento 24分前

Ovarian cancer CAR-T therapy, lira-cel, presentation to highlight positive survival observations from ongoing Phase 1 clinical trial

Breast cancer vaccine presentation to include final Phase 1 data showing all major primary endpoints were met and protocol-defined immune responses in 7

JohnnyRotton

JohnnyRotton 32分前

Wasn't to get sellers cause no one bought my sell order, cant get out now. Stuck. Just a small order.

jimr1717

jimr1717 33分前

I seriously doubt Nelson or Hawkins care who their marks are that they dump their shares on

ElectricDwarf15

ElectricDwarf15 36分前

Stuck short INHD after the T12 halt and looking to connect with anyone holding long shares who wants to exit.

I'm with Cobra DM me if interested.

knrorrel

knrorrel 37分前

$PAVD - It kicks off today. You might think—after the stock was bought up at a really nice, low price yesterday—that we’re going to skyrocket today, and all the people who didn't have the guts to buy yesterday and have been waiting on the sidelines will jump in; the stock could become a multi-dolla

ap17

Word on the street, the village Idiot, aka sims is going to change the traffic pattern. LMFAO
Don't forget! This about YOU! OUCH!!!
Might want to change that traffic pattern....so you can sit! LMFAO!!

https://www.instagram.com/p/DSS1QQ4EZk9/

Elon Musk: congratulations! Our country is lucky to have you…and you have excelled through hard work to help create the modern world more than anyone since Steve Jobs. You also are a father of many kids and are active in their lives. You have a great sense of humor and wit, and never before in histo

ace65

Up 100% ...excellent day with massive volume.
No complaints here.
Bought a chunk at .0004 and added .0005s.
Looking like .00s are coming.

knrorrel

knrorrel 42分前

It kicks off today. You might think—after the stock was bought up at a really nice, low price yesterday—that we’re going to skyrocket today, and all the people who didn't have the guts to buy yesterday and have been waiting on the sidelines will jump in; the stock could become a multi-dollar runner—

jour_trader

jour_trader 43分前

Valid question. Elite was up against a billion dollar organization known for dragging out patent protections time and time again. I think Elite and Accord’s cases brought to light the craziness of what Purdue was doing and perhaps the cases prevented further attempts at extending patents that the co

knrorrel

knrorrel 45分前

GM - watch $PAVS today, bid / ask moving higher 🚀

ddls

You know the stock is in trouble when even ddls's posts start thinning out.

Everyone's waiting for financials next year to see if any progress is being made here. Until then we should call BioElectronics Boring BIEL.

jour_trader

jour_trader 48分前

Yes, precisely. Now they can include with more certainty the financial value of Oxy in the DCF.

jour_trader

jour_trader 49分前

Nasrat will likely now be able to provide more clarification with case officially ending. Been a long road with a decent outcome. Eager to watch Accord to see what takes place with them and if they have first to file rights.

mrwrn2010

mrwrn2010 49分前

Saw that too. Possible M&A clause? 👀🧐🤔

ace65

WOW...just saw the eod Level II .WTF happened.
A high of .0037 million bought.

mrwrn2010

mrwrn2010 50分前

Even more reason to transfer full Adderall rights to Elite now. Methadone and Ropinirole alone ain’t gonna get us anywhere near the growth we need in the near term.

jour_trader

jour_trader 52分前

Also, #3 - should Elite sell or transfer ANDA…

mrwrn2010

mrwrn2010 52分前

It seems like Elite can amend the existing filing from a P IV to a P III if I’m reading the document correctly. So still, doesn’t make sense. Let us get the approval whenever and we’ll wait to launch as soon as those patents are up (assuming no one else has exclusivity).

Just give me $1.50

Just give me $1.50 55分前

Elite's attorneys are regarded, just like it's CEO.

We ain't launching Oxy until late 2028..........AT BEST.

jour_trader

jour_trader 56分前

I read that as submission to the FDA as in it buys Purdue even more time beyond the patent expiration date.

Canadian Phosphate

Helix Resources

European Resources

Elixinol Wellness

Optiscan Imaging

European Resources

OncoSil Medical

Ryzon Materials

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。